Does Metformin Slow Aging in Humans?

What This Means

Metformin is a diabetes medicine that has been used for decades. Interest in it for aging comes from laboratory work showing that it acts on cell-energy and growth pathways, including AMPK, that also change with age (Kulkarni et al., 2020; Martin-Montalvo et al., 2013). A large trial called TAME, short for Targeting Aging with Metformin, was designed to test whether the drug delays age-related disease in people (Kulkarni et al., 2020).

That is a research question, not a settled answer. The FDA-approved label for metformin lists one use: as an adjunct to diet and exercise to improve glycemic control in adults and children 10 and older with type 2 diabetes (A-S Medication Solutions, 2026). Aging is not an approved use.

Candidacy

Metformin is a prescription drug. The people for whom it has an established role are those with type 2 diabetes, and physicians also consider it for some adults with prediabetes. For a healthy person without either condition, taking it for aging is off-label and unproven, and the possible benefit has not been shown to outweigh the risks.

Some people should not take it at all. The label carries a boxed warning for lactic acidosis, a rare but serious buildup of acid in the blood, and it lists conditions that raise that risk, including kidney problems (A-S Medication Solutions, 2026). A physician decides candidacy after reviewing your history, medications and lab work.

Clinical Evaluation

If you ask about metformin, a physician evaluation usually covers:

• Your goal. Blood sugar control, weight, energy, or a general interest in longevity each lead to different advice.
• Blood sugar. Fasting glucose or HbA1c, to see whether you have diabetes or prediabetes.
• Kidney function. Checked before starting and periodically afterward, because the label ties kidney problems to higher lactic acidosis risk.
• Blood count and vitamin B12. The label advises measuring hematological parameters annually and vitamin B12 at 2 to 3 year intervals (A-S Medication Solutions, 2026).
• Medications, alcohol use and exercise habits. These affect safety and may affect results.

Available Options

The options with the strongest evidence for healthy aging are not drugs. They include regular exercise with resistance training, a balanced diet, good sleep, blood pressure and cholesterol control, and age-appropriate cancer, bone and vaccine screening.

For people with diabetes or prediabetes, metformin is a mainstream option for its approved purpose, and your physician may discuss other FDA-approved medications depending on your labs and health. In the DPP trial and its long-term follow-up (DPPOS) in high-risk adults, metformin reduced how many people developed diabetes (Knowler et al., 2025). For someone without those conditions, the reasonable alternative is to build on the basics above and revisit the question if the research changes. This article describes a published research question and is not a description of a PrimeCell service.

Benefits, Limitations and Risks

In diabetes, the benefit is lower blood sugar. For aging, no benefit has been shown in people. The risks are real even at ordinary doses:

• Stomach and bowel effects. Nausea and diarrhea are common reasons people stop the drug.
• Low vitamin B12. In the DPP/DPPOS trial cohort, low B12 was more common with metformin than placebo at 5 years (4.3% vs 2.3%), and low or borderline-low B12 was more common at 5 years (19.1% vs 9.5%) and at 13 years (20.3% vs 15.6%) (Aroda et al., 2016).
• Muscle response to exercise. In the MASTERS trial, 94 healthy adults aged 65 and older did 14 weeks of supervised resistance training. Those taking 1,700 mg of metformin per day gained less lean body mass and less thigh muscle than those taking placebo (Walton et al., 2019). Muscle matters for healthy aging, so this finding runs against the goal.
• Lactic acidosis. Rare, but it is the subject of the label's boxed warning (A-S Medication Solutions, 2026).

What the Evidence Shows

What it establishes: Metformin at 0.1% of the diet, started in middle age, extended healthspan and lifespan in male mice, while a 1% dose was toxic (Martin-Montalvo et al., 2013). Reviews describe effects on several biological hallmarks of aging in the laboratory (Kulkarni et al., 2020). In people at high risk of diabetes, metformin reduced diabetes incidence over long follow-up (Knowler et al., 2025).

What it does not establish: that metformin slows aging, extends life, or lowers disease risk in people who do not have diabetes. A 2025 review points out methodological limits in some of the early, influential observational findings, including the observation that people with diabetes on metformin lived longer than the general population. It also reports that replication attempts and trials in people without diabetes have increased uncertainty about its anti-aging potential (Keys et al., 2025). In the long-term DPPOS analysis, hazard ratios for outcomes other than diabetes incidence had confidence intervals that included no effect (Knowler et al., 2025). Mouse doses and results do not transfer directly to people.

Recovery and Next Steps

Taking a medication has no recovery period, but it does need follow-up. If you are curious about metformin, do not start it on your own or buy it from an online seller. Bring your medication and supplement list and recent labs to a visit, and say what you hope to get from it.

If you already take metformin and notice unusual muscle pain, trouble breathing, extreme tiredness, or stomach pain with vomiting, call your physician or seek emergency care promptly. Individual results vary.